NYSE · BLCO
Bausch + Lomb Corporation
$16.28 +$0.11 (+0.68%) 1D Market openKey Metrics
$5.77B
Market cap
—
P/E · TTM
$5.21B
Revenue · TTM
−$219.00M
Net income
EPS · TTM
$-0.62
Dividend yield
—
Free cash flow
$1.00M
Beta · 1Y
0.98
EBITDA · TTM
—
Gross margin
—
Snapshot
Market cap$5.77B
Enterprise value$10.54B
Shares outstanding356.5M
52-wk range$13.09 – $18.92
Avg volume · 20D609.6K
Net cash
−$4.77B
Book value / share$18.08
IndustryOphthalmic Goods
ExchangeNYSE
About Bausch + Lomb Corporation
IPO dateMay 6, 2022
Employees13000
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals.
Wolf Grade COMING SOON
—
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.
Valuation
P/E—
P/S1.11
P/FCF5,765.19
EV/EBITDA—
EV/Sales2.02
Graham №—
Profitability
Gross
—
Operating
-3.9%
Net
-4.2%
FCF
0.0%
ROE / ROIC
-3.4% · -1.9%
Financial Health
Current ratio1.53
Quick ratio0.99
Debt / equity0.79
Debt / EBITDA
—
Net cash
−$4.77B
Working capital$956.00M
Cash Flow · TTM
Operating CF
$340.00M
Capex
−$339.00M
Free cash flow
$1.00M
Buybacks
—
Dividends paid
—
Shareholder yield
—
Piotroski F-Score
3 / 9
Weak fundamentals · 3 of 9 signals passing
Altman Z-Score
0.8
Distress zone (< 1.81) · elevated risk
Graham Number vs Price
—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings